Fisher & Paykel Healthcare Corporation Limited

NZSE:FPH Voorraadrapport

Marktkapitalisatie: NZ$22.1b

Fisher & Paykel Healthcare Beheer

Beheer criteriumcontroles 3/4

De CEO Fisher & Paykel Healthcare is Lewis Gradon, benoemd in Apr2016, heeft een ambtstermijn van 8.58 jaar. De totale jaarlijkse vergoeding van { bedraagt NZ$ 3.53M, bestaande uit 50.6% salaris en 49.4% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.098% van de aandelen van het bedrijf, ter waarde NZ$ 21.61M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.5 jaar en 4.5 jaar.

Belangrijke informatie

Lewis Gradon

Algemeen directeur

NZ$3.5m

Totale compensatie

Percentage CEO-salaris50.6%
Dienstverband CEO8.6yrs
Eigendom CEO0.1%
Management gemiddelde ambtstermijn3.5yrs
Gemiddelde ambtstermijn bestuur4.5yrs

Recente managementupdates

Here's Why Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Compensation Is The Least Of Shareholders Concerns

Aug 21
Here's Why Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Compensation Is The Least Of Shareholders Concerns

Recent updates

The Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Don't Inspire Confidence

Oct 28
The Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Don't Inspire Confidence

Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shares May Have Run Too Fast Too Soon

Oct 08
Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shares May Have Run Too Fast Too Soon

Here's Why Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Compensation Is The Least Of Shareholders Concerns

Aug 21
Here's Why Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Compensation Is The Least Of Shareholders Concerns

Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

Jul 29
Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

Fisher & Paykel Healthcare (NZSE:FPH) Will Want To Turn Around Its Return Trends

Jul 11
Fisher & Paykel Healthcare (NZSE:FPH) Will Want To Turn Around Its Return Trends

Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Investors Are Less Pessimistic Than Expected

Jun 22
Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Investors Are Less Pessimistic Than Expected

There May Be Reason For Hope In Fisher & Paykel Healthcare's (NZSE:FPH) Disappointing Earnings

Jun 05
There May Be Reason For Hope In Fisher & Paykel Healthcare's (NZSE:FPH) Disappointing Earnings

Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?

Mar 27
Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?

Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Feb 22
Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Business Is Yet to Catch Up With Its Share Price

Feb 05
Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Business Is Yet to Catch Up With Its Share Price

Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 31% Above Their Intrinsic Value Estimate

Jan 03
Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 31% Above Their Intrinsic Value Estimate

We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt

Nov 30
We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt

Fisher & Paykel Healthcare (NZSE:FPH) Could Be Struggling To Allocate Capital

Nov 12
Fisher & Paykel Healthcare (NZSE:FPH) Could Be Struggling To Allocate Capital

Estimating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Aug 28
Estimating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Aug 10
Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Here's Why Fisher & Paykel Healthcare (NZSE:FPH) Can Manage Its Debt Responsibly

Jul 02
Here's Why Fisher & Paykel Healthcare (NZSE:FPH) Can Manage Its Debt Responsibly

Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

May 01
Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Returns On Capital Signal Tricky Times Ahead For Fisher & Paykel Healthcare (NZSE:FPH)

Jan 23
Returns On Capital Signal Tricky Times Ahead For Fisher & Paykel Healthcare (NZSE:FPH)

Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?

Dec 27
Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?

Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Oct 28
Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Shareholders Are Optimistic That Fisher & Paykel Healthcare (NZSE:FPH) Will Multiply In Value

Oct 13
Shareholders Are Optimistic That Fisher & Paykel Healthcare (NZSE:FPH) Will Multiply In Value

Fisher & Paykel Healthcare (NZSE:FPH) Has A Pretty Healthy Balance Sheet

Sep 28
Fisher & Paykel Healthcare (NZSE:FPH) Has A Pretty Healthy Balance Sheet

Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Jul 24
Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital

Jul 10
A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital

Fisher & Paykel Healthcare (NZSE:FPH) Seems To Use Debt Quite Sensibly

Jun 12
Fisher & Paykel Healthcare (NZSE:FPH) Seems To Use Debt Quite Sensibly

A Look At The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Apr 17
A Look At The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Fisher & Paykel Healthcare (NZSE:FPH) Could Become A Multi-Bagger

Apr 04
Fisher & Paykel Healthcare (NZSE:FPH) Could Become A Multi-Bagger

Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?

Mar 06
Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?

With EPS Growth And More, Fisher & Paykel Healthcare (NZSE:FPH) Is Interesting

Jan 22
With EPS Growth And More, Fisher & Paykel Healthcare (NZSE:FPH) Is Interesting

Why The 41% Return On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Should Have Your Attention

Dec 26
Why The 41% Return On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Should Have Your Attention

Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

Dec 05
Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

This Is The Reason Why We Think Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Deserves A Bump Up To Their Compensation

Aug 11
This Is The Reason Why We Think Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Deserves A Bump Up To Their Compensation

Is Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Worth NZ$31.6 Based On Its Intrinsic Value?

Aug 01
Is Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Worth NZ$31.6 Based On Its Intrinsic Value?

Do Fisher & Paykel Healthcare's (NZSE:FPH) Earnings Warrant Your Attention?

Jul 07
Do Fisher & Paykel Healthcare's (NZSE:FPH) Earnings Warrant Your Attention?

Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

Jun 24
Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

Analyse CEO-vergoeding

Hoe is Lewis Gradon's beloning veranderd ten opzichte van Fisher & Paykel Healthcare's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Mar 31 2024NZ$4mNZ$2m

NZ$133m

Dec 31 2023n/an/a

NZ$197m

Sep 30 2023n/an/a

NZ$262m

Jun 30 2023n/an/a

NZ$256m

Mar 31 2023NZ$3mNZ$2m

NZ$250m

Dec 31 2022n/an/a

NZ$251m

Sep 30 2022n/an/a

NZ$251m

Jun 30 2022n/an/a

NZ$314m

Mar 31 2022NZ$4mNZ$2m

NZ$377m

Dec 31 2021n/an/a

NZ$449m

Sep 30 2021n/an/a

NZ$521m

Jun 30 2021n/an/a

NZ$522m

Mar 31 2021NZ$4mNZ$2m

NZ$524m

Dec 31 2020n/an/a

NZ$458m

Sep 30 2020n/an/a

NZ$392m

Jun 30 2020n/an/a

NZ$339m

Mar 31 2020NZ$3mNZ$1m

NZ$287m

Dec 31 2019n/an/a

NZ$260m

Sep 30 2019n/an/a

NZ$233m

Jun 30 2019n/an/a

NZ$221m

Mar 31 2019NZ$3mNZ$1m

NZ$209m

Dec 31 2018n/an/a

NZ$208m

Sep 30 2018n/an/a

NZ$206m

Jun 30 2018n/an/a

NZ$198m

Mar 31 2018NZ$2mNZ$993k

NZ$190m

Compensatie versus markt: De totale vergoeding ($USD 2.11M ) Lewis } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de NZ markt ($USD 4.47M ).

Compensatie versus inkomsten: De beloning van Lewis is het afgelopen jaar met meer dan 20% gestegen, terwijl de winst van het bedrijf met meer dan 20% is gedaald.

CEO

Lewis Gradon (63 yo)

8.6yrs

Tenure

NZ$3,533,971

Compensatie

Mr. Lewis G. Gradon has been the Chief Executive Officer, Managing Director & Executive Director at Fisher & Paykel Healthcare Corporation Limited since April 1, 2016. He served as the Senior Vice Presiden...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Lewis Gradon
MD, CEO & Executive Director8.6yrsNZ$3.53m0.098%
NZ$ 21.6m
Lyndal York
Chief Financial Officer5.7yrsgeen gegevens0.0045%
NZ$ 999.1k
Andy Niccol
COO & GM of Respiratory Humidificationless than a yeargeen gegevens0.00060%
NZ$ 132.3k
Andrew Somervell
Vice President of Products & Technology8.6yrsgeen gegevens0.019%
NZ$ 4.2m
Hayden Brown
Head of Capital Markets & Investor Relationsno datageen gegevensgeen gegevens
Raelene Leonard
Company Secretary & General Counselless than a yeargeen gegevensgeen gegevens
Daniel Adolph
Senior Communications & Investor Relations Managerno datageen gegevensgeen gegevens
Justin Callahan
VP of Sales & Marketing and President of North America & Europeless than a yeargeen gegevens0.029%
NZ$ 6.3m
Nicola Talbot
Vice President of Human Resources4.1yrsgeen gegevensgeen gegevens
Jonathan Rhodes
Vice President of Supply Chain2.8yrsgeen gegevensgeen gegevens
Marcus Driller
Vice President of Corporateno datageen gegevensgeen gegevens
Chris Crone
General Manager of Airvo Optiflowno datageen gegevensgeen gegevens

3.5yrs

Gemiddelde duur

Ervaren management: Het managementteam van FPH wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.5 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Lewis Gradon
MD, CEO & Executive Director8.6yrsNZ$3.53m0.098%
NZ$ 21.6m
Michael Daniell
Non-Executive Director23yrsNZ$188.15k0.15%
NZ$ 33.9m
Neville Mitchell
Independent Chairman of the Board6yrsNZ$220.74k0.0013%
NZ$ 280.1k
Lisa E. McIntyre
Independent Non-Executive Director3.1yrsNZ$212.77k0.0023%
NZ$ 509.5k
Elspeth MacRae
Member of EcoDesign Advisory Boardno datageen gegevensgeen gegevens
Andrew Cross
Non-Executive Directorless than a yeargeen gegevensgeen gegevens
Graham McLean
Non-Executive Independent Director1.1yrsNZ$93.48k0.00032%
NZ$ 70.6k
Philippa Greenwood
Independent Non-Executive Director7.4yrsNZ$179.08k0.00065%
NZ$ 143.4k
Cather Simpson
Independent Non-Executive Director2.4yrsNZ$160.13k0.00033%
NZ$ 72.8k
David Trubridge
Member of EcoDesign Advisory Boardno datageen gegevensgeen gegevens
David Galler
Member of EcoDesign Advisory Boardno datageen gegevensgeen gegevens
Ann Smith
Member of EcoDesign Advisory Boardno datageen gegevensgeen gegevens

4.5yrs

Gemiddelde duur

63yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van FPH wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.5 jaar).